500
Participants
Start Date
July 31, 1999
Primary Completion Date
January 31, 2001
Study Completion Date
January 31, 2001
Lamivudine/Zidovudine
Nelfinavir mesylate
Stavudine
Didanosine
Anderson Clinical Research, Pittsburgh
Hampton Roads Med Specialists, Hampton
Dr Gerald Pierone Jr, Vero Beach
County Line Med CtrInc, Pembrook
Med Alternatives, Fort Lauderdale
Sorra Research Ctr / Med Forum, Birmingham
Henry Ford Hosp, Detroit
The CORE Ctr, Chicago
Univ of Texas Southwestern Med Ctr of Dallas, Dallas
Gathe, Joseph, M.D., Houston
Montrose Clinic, Houston
Body Positive, Phoenix
San Francisco Gen Hosp, San Francisco
Ohio State Univ Hosp Clinic, Columbus
Indiana Univ Med Ctr, Indianapolis
Univ of Kansas School of Medicine, Wichita
AIDS Healthcare Foundation, Los Angeles
Dartmouth-Hitchcock Med Ctr, Lebanon
NJCRI, Newark
Infectious Disease Assoc of Central Jersey, Somerville
Clinique Medicale du Quartier Latin, Montreal
Clinique Medicale L'Actuele, Montreal
Dr Roger P Leblanc, Montreal
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY